- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by National Institute of Epidemiology
Total 26863 results
-
National Cancer Institute (NCI)CompletedNSCLC | Solid Tumors | Lymphomas | Granulosa Cell Ovarian Cancer | Metastatic Colon CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedCancer | Brain MetastasisUnited States
-
Mayo ClinicNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedGastrointestinal Disease | Cancer ColonUnited States
-
National Cancer Institute (NCI)CompletedLung CancerUnited States
-
National Eye Institute (NEI)CompletedAge-Related Macular DegenerationUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Central Nervous System NeoplasmUnited States
-
National Eye Institute (NEI)Completed
-
National Cancer Institute (NCI)TerminatedMesotheliomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Malignant Neoplasm to BrainUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdrenocortical CarcinomaUnited States
-
National Eye Institute (NEI)TerminatedVon Hippel-Lindau SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingSmall Cell Lung Cancer | Extra-Pulmonary Small Cell CarcinomasUnited States
-
National Cancer Institute (NCI)CompletedRefractory Soft Tissue SarcomasUnited States
-
National Cancer Institute (NCI)CompletedDyskeratosis Congenita | Telomere Biology DisordersUnited States
-
National Cancer Institute (NCI)CompletedBurkitt Lymphoma | High-grade B-cell Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | T-cell/Histocyte-rich Large B-cell Lymphoma | Germinal Center B-cell Type (GCB)United States
-
National Cancer Institute (NCI)CompletedLymphoma | Diffuse Large B-Cell Lymphoma | Non-Hodgkin Lymphoma | Primary Central Nervous System Lymphoma | Gray-zone LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingCervical Cancer | Anal Cancer | Oropharyngeal Cancer | Vulvar, Vaginal, Penile, Rectal Cancer | HPV Positive CancerUnited States
-
National Cancer Institute (NCI)CompletedGlioma | Glioblastoma Multiforme | Giant Cell Glioblastoma | Oligodendrogliomas | Astrocytoma, Grades II, III and IVUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitation
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMetastatic Colorectal Cancer | Colorectal Neoplasms | Colorectal Tumors | Colorectal Carcinoma | Colorectal Cancer With Hepatic MetastasesUnited States
-
National Cancer Institute (NCI)SuspendedEpendymoma | Medulloblastoma | PNET | High Grade Meningioma | Primary CNS SarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingProstate Cancer | Prostate Neoplasms | Neoplasms, ProstaticUnited States
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Head and Neck NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedEpithelioid Mesothelioma | Cholangiocarcinoma, Extrahepatic | Neoplasms With Mesothelin Expression | Adenocarcinoma, PancreaticUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)CompletedMetastatic Colorectal Cancer | Hepatocellular Carcinoma | Hepatocellular Cancer | Metastatic Pancreatic Cancer | Liver MetastasisUnited States
-
National Cancer Institute (NCI)CompletedBrain TumorsUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Pancreatic Cancer | Gastrointestinal Cancer | Liver CancerUnited States
-
National Cancer Institute (NCI)CompletedOvarian Neoplasms | Ovarian Cancer | Cancer of the OvaryUnited States
-
National Cancer Institute (NCI)CompletedBurkitt Lymphoma | Plasmablastic Lymphoma | Diffuse Large B-cell Lymphoma, c-MYC PositiveUnited States
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Cholangiocarcinoma | Bile Duct Cancer | Biliary Tract Neoplasms | Liver CancerUnited States
-
National Cancer Institute (NCI)CompletedKidney CancerUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedLeukemia, Adult T-Cell | T Cell Leukemia, Adult | T Cell Leukemia, HTLV I AssociatedUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedProstate Neoplasms | Prostate Specific AntigensUnited States
-
National Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Lymphoma, Mantle CellUnited States
-
National Eye Institute (NEI)Terminated
-
National Cancer Institute (NCI)CompletedHuman Papilloma Virus | Recurrent Respiratory Papillomatosis | Laryngeal Papilloma, Recurrent | Respiratory PapillomatosisUnited States
-
National Cancer Institute (NCI)TerminatedThyroid Cancer | Low-risk Papillary Thyroid Cancer | Endocrine MalignancyUnited States
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedLeukemia, Lymphoblastic, Acute | ALL, ChildhoodUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedNeoplasms, Germ Cell and Embryonal | Lung Neoplasms | Esophageal Neoplasms | Thymus Neoplasms | MesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedLeukemia | Chronic | Lymphocytic | B-CellUnited States